Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeHOSPITALSNorthwell Health Makes History: 1st in the US to Immunize Frontline Workers...

Northwell Health Makes History: 1st in the US to Immunize Frontline Workers Against COVID-19

December 14, 2020

Northwell Health, after nearly 10 months of managing an illness that has killed nearly 300,000 and sickened more than 15 million Americans, today took a major step toward the end of the COVID-19 pandemic.

Northwell Health system made history by vaccinating the first person in the United States against COVID-19, when it injected Pfizer Inc.’s medication into Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center.

Northwell Health First in the U.S. to administer COVID-19 vaccine

Ms. Lindsay’s participation kick-started a long-anticipated vaccination deployment program throughout the US, as well as the first phase of Northwell’s three-stage rollout to essential frontline hospital personnel. Physicians, nurses and any staff member working in direct contact with COVID-19 patients will also soon receive the first of the two-dose regimen.

“Today is V-Day in our fight against COVID-19,” said Michael Dowling, Northwell president and CEO. “This truly is a historic day for science and humanity, one in which we here in New York and across the United States have been waiting for quite some time.”

After receiving the injection, Ms. Lindsay said: “I feel great. It didn’t feel any different that when receiving the annual influenza vaccine. I would like to thank all the frontline workers, all my colleagues who’ve been doing a yeoman’s job to fight this pandemic all over the world. I feel hopeful today.

“I feel relieved. I hope this marks the beginning to the end of a very painful time in our history. I want to instill public confidence that the vaccine is safe. We’re in a pandemic and so we all need to do our part to put an end to the pandemic and to not give up too soon. There’s light at the end of the tunnel.”

Northwell Health received a limited supply of a few thousands doses — to be spread among eight hospitals — of Pfizer’s vaccine, which will require two injections 21 days apart. The vaccine has demonstrated 95-percent efficacy against infection with minimal side effects, and works on messenger RNA (mRNA) technology, which has been in development for several years. mRNA instructs cells in the body to make different proteins.

To vaccinate team members, Northwell Health has prepared a three-phase prioritization matrix to help deploy the vaccine to its over 74,000 team members. The plan factors in a person’s work/geographic area, department specialty, job function and age.

To prepare, Northwell Health invested in procuring more than 20 -70F freezers, which can store about 250,000 doses each. Northwell also stocked up on extra needles, gloves, swabs to help distribute the vaccine once ready, and the health system has been working hand-in-hand with state and federal officials for a rollout.

“This is a major milestone in our battle against COVID-19 and a remarkable effort by our researchers, scientists and health care providers,” said Mark Jarrett, MD, Northwell’s chief quality officer and deputy chief medical officer. “Our detailed plan will push the seamless vaccination of these brave health care workers. We are very excited to enter the final stage of this pandemic.”

Mr. Dowling added: “COVID-19 took our loved ones, disrupted our lives and forced us to deal with unthinkable circumstances. But hope brings prosperity and we never ended our fight. We never did wave the white flag.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

By using this website you agree to accept Medical Device News Magazine Privacy Policy